This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris Infusion System has received 510(k) clearance from the US Food and Drug ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

The first technology comes under the Pyxis brand, known as the Pyxis IV system. This technology is capable of locating IV medications across the hospital and determining the status of its delivery ...

The FDA approved BD's (Becton, Dickinson, and Company) (NYSE:BDX) BD Alaris Infusion System with 510(k) clearance, which enables both remediation and a return to full commercial operations for the ...

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...

The Qualcomm Life Capsule Datacaptor Terminal Server and the Becton Dickinson Alaris TIVA Syringe Pump allow remote access without authentication. Two previously undocumented, critical vulnerabilities ...

For BD, bad things seem to come in eights: The medtech giant issued a cybersecurity bulletin Thursday describing an octad of potential hacking risks it has discovered within certain versions of its ...

BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medication technology ...